Roanoke Asset Management Corp Gilead Sciences, Inc. Transaction History

Roanoke Asset Management Corp

$318 Million
Q3 2024

A detailed history of Roanoke Asset Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Roanoke Asset Management Corp holds 34,561 shares of GILD stock, worth $3.1 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

34,561

Previous 34,099 1.35%

Holding current value

$3.1 Million

Previous $2.34 Million 23.85%

% of portfolio

0.91%

Previous 0.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$66.59 - $83.99 $30,764 - $38,803	462 Added 1.35%	34,561 $2.9 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $13,324 - $15,377	-211 Reduced 0.61%	34,099 $2.34 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $858 - $1,047	12 Added 0.03%	34,310 $2.51 Million
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $879 - $997	12 Added 0.03%	34,298 $2.78 Million
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $1,774 - $1,936	-24 Reduced 0.07%	34,286 $2.57 Million
Q2 2023 Jul 31, 2023	BUY	$76.01 - $86.7 $912 - $1,040	12 Added 0.03%	34,310 $2.64 Million
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $850 - $968	11 Added 0.03%	34,298 $2.85 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $623 - $894	10 Added 0.03%	34,287 $2.94 Million
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $31,972 - $36,521	-537 Reduced 1.54%	34,277 $2.12 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $33,881 - $38,160	-587 Reduced 1.66%	34,814 $2.15 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $10,831 - $13,572	-187 Reduced 0.53%	35,401 $2.11 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $713 - $810	11 Added 0.03%	35,588 $2.58 Million
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.0%	35,577 $2.49 Million
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $229,253 - $250,492	3,612 Added 11.3%	35,576 $2.45 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $311,520 - $355,444	-5,192 Reduced 13.97%	31,964 $2.07 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $10,366 - $11,812	183 Added 0.49%	37,156 $2.17 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $24,156 - $30,373	-389 Reduced 1.04%	36,973 $2.34 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $191,773 - $222,684	-2,651 Reduced 6.63%	37,362 $2.88 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $23,486 - $30,082	375 Added 0.95%	40,013 $2.99 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $485,873 - $534,445	-7,885 Reduced 16.59%	39,638 $2.58 Million
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $23,128 - $25,530	-370 Reduced 0.77%	47,523 $3.01 Million
Q2 2019 Jul 19, 2019	BUY	$61.87 - $69.38 $12,002 - $13,459	194 Added 0.41%	47,893 $3.24 Million
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $2,501 - $2,802	-40 Reduced 0.08%	47,699 $3.1 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $8,536 - $11,139	-141 Reduced 0.29%	47,739 $2.99 Million
Q3 2018 Oct 30, 2018	SELL	$71.28 - $78.92 $10,549 - $11,680	-148 Reduced 0.31%	47,880 $3.7 Million
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $29,195 - $34,056	-450 Reduced 0.93%	48,028 $3.4 Million
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $131,112 - $159,840	1,800 Added 3.86%	48,478 $3.66 Million
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $159,233 - $186,917	-2,238 Reduced 4.58%	46,678 $3.34 Million
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $3.53 Million - $4.18 Million	48,916	48,916 $3.96 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.

Account

Roanoke Asset Management Corp Gilead Sciences, Inc. Transaction History